Latvia vs Türkiye: Communicable diseases — Communicable disease incidence
Communicable diseases — Communicable disease incidence over time
- Latvia
- Türkiye
How they compare
Türkiye currently reports 132 Cases against 46 Cases in Latvia, a difference of 86 Cases.
That makes Türkiye's figure about 2.9 times Latvia's.
The two have swapped places 3 times across 20 shared years of data; in 2005 it was Latvia ahead.
Latvia ranks 4th and Türkiye ranks 3rd of 7 countries.
Across the 3 decades both report, Latvia averaged higher in 2 and Türkiye in 1.
Head to head by decade
| Decade | Latvia | Türkiye | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 98.8 Cases | 42.8 Cases | 56 Cases | Latvia |
| 2010s | 124.3 Cases | 101.5 Cases | 22.8 Cases | Latvia |
| 2020s | 48.6 Cases | 84.4 Cases | 35.8 Cases | Türkiye |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher communicable diseases — communicable disease incidence, Latvia or Türkiye?
- Türkiye, at 132 Cases against 46 Cases in Latvia as of 2024.
- What is the difference in communicable diseases — communicable disease incidence between Latvia and Türkiye?
- 86 Cases, with Türkiye ahead.
- How many years of comparable data are there for Latvia and Türkiye?
- 20 years are reported by both, from 2005 to 2024.
- How do Latvia and Türkiye rank globally for communicable diseases — communicable disease incidence?
- Latvia ranks 4th and Türkiye ranks 3rd of 7 countries.
- Where does this data come from?
- Organisation for Economic Co-operation and Development, published as Communicable diseases — Communicable disease incidence. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
This dataset presents time series on Acquired Immunodeficiency Syndrome (AIDS), for the number of AIDS cases and incidence rates per 100 000 population at year of diagnosis. It also includes data on incidence of pertussis, measles, and hepatitis B, in terms of rates of reported cases per 100 000 population. Please refer to the Sources and Methods for detailed country-specific information.